Search results for: Innovation Policy Prize
Filter search results
Collected Essays by Tony Culyer on Health Economics
25 November 2012
…can be applied in health care decision making, carefully teasing out the potential conflicts between different definitions. Health policy. Culyer’s approach to health policy is to clarify objectives, then evaluate…
OHE Lunchtime Seminar: Improving Sustainability through Needs-Based Planning
31 December 2014
…a paper published in the Journal of Health Services Research & Policy [2], Birch and colleagues argue that planning on the basis of a fixed production function is inappropriate, and…
The Economics of the Private Finance Initiative in the NHS
4 January 2001
…capital in the NHS, capital expenditure trends and official policy, including the introduction of capital charges and other pressures to use capital assets efficiently. Chapter 3 places the PFI in…
Spotlight on OHE: Making Health Care Choices and Decisions
7 January 2013
…presented some new data on competitive procurement of health care services by NHS commissioners. Provider Competition in the NHS — Economics and Policy from Office of Health Economics Approaches to…
2015 OHE Annual Lecture: Regulation, Reimbursement, and Evidence on New Medical Technologies: Experiences and Future Directions in the United States
10 June 2015
…McClellan, MD, PhD, is a Senior Fellow and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. His work focuses on strategies and policy…
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…governments to counter the downturn with fiscal and monetary policy support (World Bank, 2020). A vaccine that would effectively prevent this disease will, therefore, have a broad value to society…
OHE responds to the Trump administration’s Executive Order on Drug Prices
14 May 2025
…burden-sharing. In this case, others are expected to contribute more fairly to global pharmaceutical innovation by paying higher prices. Given US voters’ very real dissatisfaction with high drug prices, this…
Dimitrios Kourouklis
16 June 2020
Dimitrios is an economist and his research interests lie in the fields of the economics of innovation and specifically on the economics of pharmaceutical markets and R&D. In addition, he…
Measuring Value with Pharmacoeconomics
26 May 2011
…reimbursement price considering incremental health-related effects and costs compared to existing treatments. Australia was the first to adopt such a policy, in 1993, followed quickly by New Zealand and several…